Saba Capital Management, L.P. bought HQL
June 12, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 2,400 shares of Abrdn Life Sciences Investors at $13.88 per share, a transaction worth $33.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,400
Price
$13.88
Total value
$33.3K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 12, 2024
Filing dateJune 14, 2024
Shares owned after3,407,612
OwnershipIndirect
10b5-1 planNo
AmendedNo